BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, Chaisson RE. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet 2015;386:2344-53. [PMID: 26515679 DOI: 10.1016/S0140-6736(15)00323-2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 47] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Saunders MJ, Evans CA. COVID-19, tuberculosis and poverty: preventing a perfect storm. Eur Respir J 2020;56:2001348. [PMID: 32444399 DOI: 10.1183/13993003.01348-2020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 31.0] [Reference Citation Analysis]
2 Kay AW, Thivalapill N, Skinner D, Dube GS, Dlamini N, Mzileni B, Fuentes P, Ustero P, Adams LV, Mandalakas AM. Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV. PLoS One 2020;15:e0243713. [PMID: 33332462 DOI: 10.1371/journal.pone.0243713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Parvaresh L, Bag SK, Cho JG, Heron N, Assareh H, Norton S, Corbett S, Marais BJ. Monitoring tuberculosis contact tracing outcomes in Western Sydney, Australia. BMJ Open Respir Res 2018;5:e000341. [PMID: 30397487 DOI: 10.1136/bmjresp-2018-000341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Dorjee K, Topgyal S, Dorjee C, Tsundue T, Namdol T, Tsewang T, Nangsel T, Lhadon D, Choetso T, Dawa T, Phentok T, DeLuca AN, Tsering L, Phunkyi D, Sadutshang TD, J Bonomo E, Paster Z, Chaisson RE. High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children. Clin Infect Dis 2019;69:760-8. [PMID: 30462191 DOI: 10.1093/cid/ciy987] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
5 MacPherson P, Lebina L, Motsomi K, Bosch Z, Milovanovic M, Ratsela A, Lala S, Variava E, Golub JE, Webb EL, Martinson NA. Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial. PLoS One 2020;15:e0230376. [PMID: 32182274 DOI: 10.1371/journal.pone.0230376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Scandurra G, Degeling C, Douglas P, Dobler CC, Marais B. Tuberculosis in migrants - screening, surveillance and ethics. Pneumonia (Nathan) 2020;12:9. [PMID: 32923311 DOI: 10.1186/s41479-020-00072-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Huynh J, Marais BJ. Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs. Ther Adv Infect Dis 2019;6:2049936119864737. [PMID: 31367376 DOI: 10.1177/2049936119864737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Saunders MJ, Datta S. Contact Investigation: A Priority for Tuberculosis Control Programs. Am J Respir Crit Care Med 2016;194:1049-51. [PMID: 27797611 DOI: 10.1164/rccm.201605-1007ED] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 du Plessis WJ, Kleynhans L, du Plessis N, Stanley K, Malherbe ST, Maasdorp E, Ronacher K, Chegou NN, Walzl G, Loxton AG. The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis. PLoS One 2016;11:e0152710. [PMID: 27050308 DOI: 10.1371/journal.pone.0152710] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
10 van de Water BJ, Meyer TN, Wilson M, Young C, Gaunt B, le Roux KW. TB prevention cascade at a district hospital in rural Eastern Cape, South Africa. Public Health Action 2021;11:97-100. [PMID: 34159070 DOI: 10.5588/pha.20.0055] [Reference Citation Analysis]
11 Comella-Del-Barrio P, Molina-Moya B, Gautier J, Villar-Hernández R, Doresca MJC, Sallés-Mingels B, Canales-Aliaga L, Narcisse M, Pérez-Porcuna TM, Creswell J, Cuevas LE, Domínguez J. Diagnostic Performance of the Fujifilm SILVAMP TB-LAM in Children with Presumptive Tuberculosis. J Clin Med 2021;10:1914. [PMID: 33925008 DOI: 10.3390/jcm10091914] [Reference Citation Analysis]
12 Yuen CM, Millones AK, Puma D, Jimenez J, Galea JT, Calderon R, Pages GS, Brooks MB, Lecca L, Nicholson T, Becerra MC, Keshavjee S. Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru. PLoS One 2021;16:e0247411. [PMID: 33606824 DOI: 10.1371/journal.pone.0247411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Eshetie S, Gizachew M, Alebel A, van Soolingen D. Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis. PLoS One 2018;13:e0194675. [PMID: 29554144 DOI: 10.1371/journal.pone.0194675] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
14 Hannah A, Dick M. Identifying gaps in the quality of latent tuberculosis infection care. J Clin Tuberc Other Mycobact Dis 2020;18:100142. [PMID: 31956699 DOI: 10.1016/j.jctube.2020.100142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Telisinghe L, Amofa-Sekyi M, Maluzi K, Kaluba-Milimo D, Cheeba-Lengwe M, Chiwele K, Kosloff B, Floyd S, Bailey SL, Ayles H. The sensitivity of the QuantiFERON®-TB Gold Plus assay in Zambian adults with active tuberculosis. Int J Tuberc Lung Dis 2017;21:690-6. [PMID: 28482964 DOI: 10.5588/ijtld.16.0764] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
16 Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, Gendelman HE, Gordon R, Hesseling A, Le Van H, Kampmann B, Kana B, Khuller G, Lewinsohn DM, Lewinsohn DA, Lin PL, Lu LL, Maartens G, Owen A, Protopopova M, Rengarajan J, Rubin E, Salgame P, Schurr E, Seddon JA, Swindells S, Tobin DM, Udwadia Z, Walzl G, Srinivasan S, Rustomjee R, Nahid P. Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. Am J Respir Crit Care Med 2019;199:564-71. [PMID: 30335466 DOI: 10.1164/rccm.201806-1053PP] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 15.0] [Reference Citation Analysis]
17 Liu J, Jiang H, Zhang H, Guo C, Wang L, Yang J, Nie S. Use of social network analysis and global sensitivity and uncertainty analyses to better understand an influenza outbreak. Oncotarget 2017;8:43417-26. [PMID: 28177887 DOI: 10.18632/oncotarget.15076] [Reference Citation Analysis]
18 Saunders MJ, Wingfield T, Tovar MA, Baldwin MR, Datta S, Zevallos K, Montoya R, Valencia TR, Friedland JS, Moulton LH, Gilman RH, Evans CA. A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study. Lancet Infect Dis 2017;17:1190-9. [PMID: 28827142 DOI: 10.1016/S1473-3099(17)30447-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 27] [Article Influence: 12.8] [Reference Citation Analysis]
19 Islam MS, Chughtai AA, Nazneen A, Chowdhury KIA, Islam MT, Tarannum S, Islam SMH, Banu S, Seale H. A tuberculin skin test survey among healthcare workers in two public tertiary care hospitals in Bangladesh. PLoS One 2020;15:e0243951. [PMID: 33332458 DOI: 10.1371/journal.pone.0243951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Majumdar SS, Triasih R, Graham SM. Scaling up tuberculosis preventive therapy for contacts in high transmission settings. Lancet Glob Health 2020;8:e617-8. [PMID: 32353300 DOI: 10.1016/S2214-109X(20)30133-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Jenkins HE, Yuen CM, Rodriguez CA, Nathavitharana RR, McLaughlin MM, Donald P, Marais BJ, Becerra MC. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2017;17:285-95. [PMID: 27964822 DOI: 10.1016/S1473-3099(16)30474-1] [Cited by in Crossref: 85] [Cited by in F6Publishing: 54] [Article Influence: 17.0] [Reference Citation Analysis]
22 Huaman MA, Sterling TR. Treatment of Latent Tuberculosis Infection-An Update. Clin Chest Med 2019;40:839-48. [PMID: 31731988 DOI: 10.1016/j.ccm.2019.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
23 Churchyard GJ, Swindells S. Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB. PLoS Med 2019;16:e1002787. [PMID: 31013273 DOI: 10.1371/journal.pmed.1002787] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
24 Naidoo K, Gengiah S, Singh S, Stillo J, Padayatchi N. Quality of TB care among people living with HIV: Gaps and solutions. J Clin Tuberc Other Mycobact Dis 2019;17:100122. [PMID: 31788564 DOI: 10.1016/j.jctube.2019.100122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Cabrera-Gaytán DA, Niebla-Fuentes MD, Padilla-Velázquez R, Valle-Alvarado G, Arriaga-Nieto L, Rojas-Mendoza T, Rosado-Quiab U, Grajales-Muñiz C, Vallejos-Parás A. Association of Pulmonary Tuberculosis and HIV in the Mexican Institute of Social Security, 2006-2014. PLoS One 2016;11:e0168559. [PMID: 28033402 DOI: 10.1371/journal.pone.0168559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
26 DeLuca A, Dhumal G, Paradkar M, Suryavanshi N, Mave V, Kohli R, Shivakumar SVBY, Hulyolkar V, Gaikwad A, Nangude A, Pardeshi G, Kadam D, Gupta A. Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: a vital part of elimination. BMC Infect Dis 2018;18:202. [PMID: 29720095 DOI: 10.1186/s12879-018-3116-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Chandra DK, Moll AP, Altice FL, Didomizio E, Andrews L, Shenoi SV. Structural barriers to implementing recommended tuberculosis preventive treatment in primary care clinics in rural South Africa. Glob Public Health 2021;:1-14. [PMID: 33650939 DOI: 10.1080/17441692.2021.1892793] [Reference Citation Analysis]
28 Doddam SN, Peddireddy V, Ahmed N. Mycobacterium tuberculosis DosR Regulon Gene Rv2004c Encodes a Novel Antigen with Pro-inflammatory Functions and Potential Diagnostic Application for Detection of Latent Tuberculosis. Front Immunol 2017;8:712. [PMID: 28694808 DOI: 10.3389/fimmu.2017.00712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
29 Mac TH, Phan TH, Nguyen VV, Dong TTT, Le HV, Nguyen QD, Nguyen TD, Codlin AJ, Mai TDT, Forse RJ, Nguyen LP, Luu THT, Nguyen HB, Nguyen NV, Pham XT, Tran PN, Khan A, Vo LNQ, Creswell J. Optimizing Active Tuberculosis Case Finding: Evaluating the Impact of Community Referral for Chest X-ray Screening and Xpert Testing on Case Notifications in Two Cities in Viet Nam. Trop Med Infect Dis 2020;5:E181. [PMID: 33265972 DOI: 10.3390/tropicalmed5040181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Adegbite BR, Edoa JR, Achimi Agbo P, Dejon-Agobé JC, N Essone P, Lotola-Mougeni F, Mbong Ngwese M, Mfoumbi A, Mevyann C, Epola M, Zinsou JF, Honkpehedji YJ, Agnandji ST, Kremsner PG, Alabi AS, Adegnika AA, Grobusch MP. Epidemiological, Mycobacteriological, and Clinical Characteristics of Smoking Pulmonary Tuberculosis Patients, in Lambaréné, Gabon: A Cross-Sectional Study. Am J Trop Med Hyg 2020;103:2501-5. [PMID: 32975178 DOI: 10.4269/ajtmh.20-0424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ledesma JR, Ma J, Zheng P, Ross JM, Vos T, Kyu HH. Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis. BMC Infect Dis 2021;21:467. [PMID: 34022827 DOI: 10.1186/s12879-021-06141-4] [Reference Citation Analysis]
32 Cazabon D, Alsdurf H, Satyanarayana S, Nathavitharana R, Subbaraman R, Daftary A, Pai M. Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade. Int J Infect Dis 2017;56:111-6. [PMID: 27794468 DOI: 10.1016/j.ijid.2016.10.016] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 15.4] [Reference Citation Analysis]
33 Churchyard G, Kim P, Shah NS, Rustomjee R, Gandhi N, Mathema B, Dowdy D, Kasmar A, Cardenas V. What We Know About Tuberculosis Transmission: An Overview. J Infect Dis 2017;216:S629-35. [PMID: 29112747 DOI: 10.1093/infdis/jix362] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 17.3] [Reference Citation Analysis]
34 Yuen CM, Amanullah F, Dharmadhikari A, Nardell EA, Seddon JA, Vasilyeva I, Zhao Y, Keshavjee S, Becerra MC. Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment. Lancet 2015;386:2334-43. [PMID: 26515675 DOI: 10.1016/S0140-6736(15)00322-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 51] [Article Influence: 12.3] [Reference Citation Analysis]
35 Main S, Lestari T, Triasih R, Chan G, Davidson L, Majumdar S, Santoso D, Phung S, Laukkala J, Graham S, du Cros P, Ralph A. Training for Tuberculosis Elimination in Indonesia: Achievements, Reflections, and Potential for Impact. Trop Med Infect Dis 2019;4:E107. [PMID: 31323840 DOI: 10.3390/tropicalmed4030107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Yuen CM, Millones AK, Galea JT, Puma D, Jimenez J, Lecca L, Becerra MC, Keshavjee S. Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru. BMC Public Health 2021;21:121. [PMID: 33430823 DOI: 10.1186/s12889-020-10098-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zegarra-Chapoñan R, Bonadonna LV, Yuen CM, Martina-Chávez MB, Zeladita-Huaman J. Implementation of isoniazid preventive therapy in southern Lima, Peru: an analysis of health center characteristics. Infect Dis Poverty 2021;10:63. [PMID: 33962691 DOI: 10.1186/s40249-021-00845-0] [Reference Citation Analysis]
38 Yuen CM, Majidulla A, Jaswal M, Safdar N, Malik AA, Khan AJ, Becerra MC, Keshavjee S, Lu C, Hussain H. Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting. Clin Infect Dis 2021;73:e1135-41. [PMID: 33289039 DOI: 10.1093/cid/ciaa1835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Shi CL, Zhang JP, Xu P, Li J, Shen J, Wu MY, Ye ZJ, Yu X, Song HF, Chen H, Xu JC, Pang Y, Huang JA. Upregulation of PD-1 expression on circulating CD8+ but not CD4+ T cells is associated with tuberculosis infection in health care workers. BMC Immunol 2021;22:39. [PMID: 34172011 DOI: 10.1186/s12865-021-00433-9] [Reference Citation Analysis]
40 Osei E, Oppong S, Adanfo D, Doepe BA, Owusu A, Kupour AG, Der J. Reflecting on tuberculosis case notification and treatment outcomes in the Volta region of Ghana: a retrospective pool analysis of a multicentre cohort from 2013 to 2017. Glob Health Res Policy 2019;4:37. [PMID: 31890895 DOI: 10.1186/s41256-019-0128-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Jeon D. Latent tuberculosis infection: recent progress and challenges in South Korea. Korean J Intern Med 2020;35:269-75. [PMID: 32131570 DOI: 10.3904/kjim.2020.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
42 Yuen CM, Seddon JA, Keshavjee S, Dodd PJ. Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study. Lancet Glob Health 2020;8:e672-80. [PMID: 32353315 DOI: 10.1016/S2214-109X(20)30075-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
43 Ortblad KF, Salomon JA, Bärnighausen T, Atun R. Stopping tuberculosis: a biosocial model for sustainable development. Lancet 2015;386:2354-62. [PMID: 26515678 DOI: 10.1016/S0140-6736(15)00324-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 22] [Article Influence: 8.5] [Reference Citation Analysis]
44 Kendall EA, Sahu S, Pai M, Fox GJ, Varaine F, Cox H, Cegielski JP, Mabote L, Vassall A, Dowdy DW. What will it take to eliminate drug-resistant tuberculosis? Int J Tuberc Lung Dis 2019;23:535-46. [PMID: 31097060 DOI: 10.5588/ijtld.18.0217] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
45 Basnyat B, Caws M, Udwadia Z. Tuberculosis in South Asia: a tide in the affairs of men. Multidiscip Respir Med 2018;13:10. [PMID: 29599974 DOI: 10.1186/s40248-018-0122-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
46 Rodríguez-Flores EM, Mata-Espinosa D, Barrios-Payan J, Marquina-Castillo B, Castañón-Arreola M, Hernández-Pando R. A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies. PLoS One 2019;14:e0217457. [PMID: 31145751 DOI: 10.1371/journal.pone.0217457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Telisinghe L, Charalambous S, Topp SM, Herce ME, Hoffmann CJ, Barron P, Schouten EJ, Jahn A, Zachariah R, Harries AD, Beyrer C, Amon JJ. HIV and tuberculosis in prisons in sub-Saharan Africa. Lancet 2016;388:1215-27. [PMID: 27427448 DOI: 10.1016/S0140-6736(16)30578-5] [Cited by in Crossref: 60] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]